PCVX.O (PCVX.O) News
Follow PCVX.O (PCVX.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Vaxcyte commences offerings of common stock, warrants and notes
Vaxcyte Inc. announced the commencement of proposed offerings of common stock, pre-funded warrants, and convertible senior notes, aiming to raise funds for clinical development of its Vax-31 programs, manufacturing scale
EQUITY | Oct 05, 2026, 09:35 PM UTC
M
Vaxcyte launches $500 million convertible senior notes offering
Vaxcyte launched an underwritten public offering of USD 500 million of convertible senior notes due 2032. Notes are set to mature on Oct. 15, 2032, with the interest rate and initial conversion rate to be fixed at pricin
MNA | Oct 05, 2026, 08:30 PM UTC